期刊
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
卷 879, 期 25, 页码 2561-2566出版社
ELSEVIER
DOI: 10.1016/j.jchromb.2011.07.012
关键词
Vandetanib (ZD6474); Human plasma and cerebrospinal fluid (CSF); Liquid-liquid extraction (LLE); Liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS); Lower limit of quantitation (LLOQ)
资金
- NIH [P01 CA 23099]
- Cancer Center [CA 21765]
- ALSAC
A sensitive and precise LC-ESI-MS/MS method for the determination of vandetanib (ZD6474) in human plasma and cerebrospinal fluid (CSF) using [C-13,d(3)]-ZD6474 as an internal standard (ISTD) was developed and validated. Sample preparation consisted of a simple liquid-liquid extraction with tert-butyl methyl ether containing 0.1% or 0.5% ammonium hydroxide. ZD6474 and ISTD were separated on a Kinetex C18 column (2.6 mu m. 50 mm x 2.1 mm) at ambient temperature with an isocratic mobile phase (acetonitrile/10 mM ammonium formate = 50/50, v/v, at pH 5.0) delivered at 0.11 mL/min. The retention time of both compounds was at 1.60 min in a runtime of three min. Detection was achieved by an API-3200 LC-MS/MS system, monitoring m/z 475.1/112.1 and m/z 479.1/116.2 for vandetanib and ISTD, respectively. The method was linear in the range of 0.25-50 ng/mL (R-2 >= 0.990) for the CSF curve and from 1.0 to 3000 ng/mL (R-2 >= 0.992) for the plasma curve. The mean recovery for vandetanib was 80%. Within-day and between-day precisions were <= 8.8% and <= 5.9% for CSF and plasma, respectively. Within-day and between-day accuracies ranged from 95.0 to 98.5% for CSF, and from 104.0 to 108.5% for plasma. Analysis of plasma from six different sources showed no matrix effect for vandetanib (MF=0.98, %CV <= 4.97, n = 6). This method was successfully applied to the analysis of pharmacokinetic samples from children with brain tumors treated with oral vandetanib. (C) 2011 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据